CBT for generalized anxiety

For adults with generalized anxiety disorder, structured CBT can reduce excessive worry and anxiety. Research also supports some other structured therapies. Digital delivery can mean a therapist working over video or a guided program; it should not be confused with an untested automated conversation.

Literature checked · Review methods and limits

Clinical context

The clinical focus is persistent, difficult-to-control worry and its effects on everyday functioning, rather than occasional uncertainty. Historical Canadian guidance emphasizes assessment, comorbidity, and functional impairment when distinguishing anxiety disorders from ordinary anxiety (Katzman et al., 2014). Occasional worry does not by itself establish a diagnosis. NICE describes treatment within stepped care, while WHO’s 2023 recommendation supports brief, structured CBT-based psychological interventions for adults with GAD or panic disorder (NICE, 2011; World Health Organization [WHO], 2023).

Sources: Katzman et al., 2014; NICE, 2011; World Health Organization, 2023

Evidence and alternatives

In the corrected network meta-analysis, Papola et al. (2024) included 65 trials and 5,048 adults. CBT was associated with fewer GAD symptoms than treatment as usual: SMD−0.74 (95% CI −1.09 to−0.38), with published moderate CINeMA confidence for that comparison. Third-wave CBT approaches also performed better than usual care, without reliable differences between active psychotherapies. The result supports a family of structured approaches; it does not identify one universally best treatment or establish that different methods are equivalent for every patient.

Sources: Papola et al., 2024

Why correction and follow-up matter

The published correction removed a duplicated cohort and fixed an extraction error involving a standard error and standard deviation. Analyses were rerun without changing the main clinical interpretation. This example makes version checking part of evidence interpretation, not a clerical afterthought (“Errors in Network Meta-analysis,” 2024). Follow-up evidence generally supports retained gains, but the long-term anxiety review noted limited-quality trials and scarce relapse evidence (van Dis et al., 2020).

Sources: "Errors in network meta-analysis", 2024; van Dis et al., 2020

What remote treatment evidence means

A 2024 randomized trial of 78 adults compared therapist-delivered videoconference CBT with a waitlist and found better symptom outcomes after treatment. This tests a remote clinical service, not replacement of the therapist by software. Its mostly female sample, waitlist comparison, and short treated-group follow-up limit generalization and claims of parity with in-person care. Its practical contribution is evidence that location need not prevent delivery of an assessed, structured therapy (Trenoska Basile et al., 2024).

Sources: Trenoska Basile et al., 2024

What remains uncertain

Cognitive restructuring and behavioural experiments differ from acceptance-based approaches that change a person’s relationship to thoughts. A broad third-wave category cannot establish the effectiveness of every ACT, DBT, mindfulness, or REBT exercise. A further research question is whether a defined worry-focused digital feature improves functioning beyond an equally credible reflection tool. Longer follow-up, meaningful adverse-event reporting, and diverse samples remain important. Adult estimates are separate from youth evidence, and confidence in clinician-led CBT cannot be transferred to Ella.

Sources: Papola et al., 2024; World Health Organization, 2023; Trenoska Basile et al., 2024

References

Links open the original papers or official sources. Access labels describe the material assessed for this review.

Clinical guidance · 2014

Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group (2014). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry, 14(Suppl. 1), S1. 10.1186/1471-244X-14-S1-S1

Access assessed: full text, PMC; initial challenge resolved on final recheck

Clinical guidance · 2011

National Institute for Health and Care Excellence (2011). Generalised anxiety disorder and panic disorder in adults: Management. NICE clinical guideline CG113.

Access assessed: official indexed public-information/recommendation excerpts; direct403

Clinical guidance · 2023

World Health Organization (2023). Brief structured psychological interventions.

Access assessed: full official recommendation webpage

Publication · 2024

Papola, D., Miguel, C., Mazzaglia, M., Franco, P., Tedeschi, F., Romero, S. A., Patel, A. R., Ostuzzi, G., Gastaldon, C., Karyotaki, E., Harrer, M., Purgato, M., Sijbrandij, M., Patel, V., Furukawa, T. A., Cuijpers, P., & Barbui, C. (2024). Psychotherapies for generalized anxiety disorder in adults: A systematic review and network meta-analysis of randomized clinical trials. JAMA Psychiatry, 81(3), 250–259. 10.1001/jamapsychiatry.2023.3971

Access assessed: corrected full text, publisher

Publication · 2020

van Dis, E. A. M., van Veen, S. C., Hagenaars, M. A., Batelaan, N. M., Bockting, C. L. H., van den Heuvel, R. M., Cuijpers, P., & Engelhard, I. M. (2020). Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: A systematic review and meta-analysis. JAMA Psychiatry, 77(3), 265–273. 10.1001/jamapsychiatry.2019.3986

Access assessed: primary abstract and indexed full-text excerpts; PMC challenge/repository403

Publication · 2024

Trenoska Basile, V., Newton-John, T., McDonald, S., & Wootton, B. M. (2024). Internet videoconferencing delivered cognitive behaviour therapy for generalized anxiety disorder: A randomized controlled trial. British Journal of Clinical Psychology, 63(4), 487–506. 10.1111/bjc.12482

Access assessed: full text, publisher

Explore the full source library

This evidence review is educational. It does not provide an individual diagnosis or treatment plan. Read the review methods, access limits, and clinical-review status.